StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen accumulated depreciation ($M) ($M)

Form 10-K (DB)

QuarterlyAnnual
Latest, FY2025
-11,100
Period ended Dec 31, 2025
Change on a year earlier
+6.9%
-10,388 in FY2024
History
17 years
Since FY2009
Sources
17
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccumulated depreciation ($M) ($M)Year on yearSource
FY2025Dec 31, 2025-11,100+6.9%Form 10-Q (filed 2026-05-01) ↗
FY2024Dec 31, 2024-10,388+5.9%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 2023-9,808+5.7%Form 10-K (filed 2025-02-14) ↗
FY2022Dec 31, 2022-9,283+5.5%Form 10-K (filed 2024-02-14) ↗
FY2021Dec 31, 2021-8,798-2.0%Form 10-K (filed 2023-02-09) ↗
FY2020Dec 31, 2020-8,977+7.4%Form 10-K (filed 2022-02-16) ↗
FY2019Dec 31, 2019-8,357+7.2%Form 10-K (filed 2021-02-09) ↗
FY2018Dec 31, 2018-7,796+2.7%Form 10-K (filed 2020-02-12) ↗
FY2017Dec 31, 2017-7,590+1.7%Form 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 2016-7,466+2.8%Form 10-K (filed 2018-02-13) ↗
FY2015Dec 31, 2015-7,265+3.3%Form 10-K (filed 2017-02-14) ↗
FY2014Dec 31, 2014-7,033+1.3%Form 10-K (filed 2016-02-16) ↗
FY2013Dec 31, 2013-6,942+4.8%Form 10-K (filed 2015-02-19) ↗
FY2012Dec 31, 2012-6,621+13.9%Form 10-K (filed 2014-02-24) ↗
FY2011Dec 31, 2011-5,811+0.2%Form 10-K (filed 2013-02-27) ↗
FY2010Dec 31, 2010-5,800+25.1%Form 10-Q (filed 2012-05-08) ↗

Cite this data

StockData. (2026). Amgen Accumulated depreciation ($M) ($M), annual FY2009–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_accum_depr

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.